ERTÜRK ŞENGEL, B. Et Al. 2021. Impact of tocilizumab on clinical outcomes in severe COVID-19 patients and risk of secondary infection: A case-control study. MARMARA MEDICAL JOURNAL , vol.34, no.2 , 112-119.

ERTÜRK ŞENGEL, B., Ozel, S., Gul, F., ILGIN, C., TİGEN, E., Altunal, L. N., ... KABADAYI, F.(2021). Impact of tocilizumab on clinical outcomes in severe COVID-19 patients and risk of secondary infection: A case-control study. MARMARA MEDICAL JOURNAL , vol.34, no.2, 112-119.

ERTÜRK ŞENGEL, BUKET Et Al. "Impact of tocilizumab on clinical outcomes in severe COVID-19 patients and risk of secondary infection: A case-control study," MARMARA MEDICAL JOURNAL , vol.34, no.2, 112-119, 2021

ERTÜRK ŞENGEL, BUKET E. Et Al. "Impact of tocilizumab on clinical outcomes in severe COVID-19 patients and risk of secondary infection: A case-control study." MARMARA MEDICAL JOURNAL , vol.34, no.2, pp.112-119, 2021

ERTÜRK ŞENGEL, B. Et Al. (2021) . "Impact of tocilizumab on clinical outcomes in severe COVID-19 patients and risk of secondary infection: A case-control study." MARMARA MEDICAL JOURNAL , vol.34, no.2, pp.112-119.

@article{article, author={BUKET ERTÜRK ŞENGEL Et Al. }, title={Impact of tocilizumab on clinical outcomes in severe COVID-19 patients and risk of secondary infection: A case-control study}, journal={MARMARA MEDICAL JOURNAL}, year=2021, pages={112-119} }